AKP

Company Profile

AKP was founded in 1996 as a spin-off from IKP (Institut für klinische Pharmakologie) by Priv.-Doz. Dr. med. K.-U. Seiler and Prof. Dr. med. P.-W. Lücker.

With 27 years experience, AKP has achieved a proven record of broad services partnering innovative pharmaceutical companies in managing international and national clinical trials, and non-interventional and Medical Device studies in a vast variety of therapeutic areas.

As an exclusive service provider we partner your company and offer flexible solutions; whether you are looking for us to manage your project from beginning to end or provide customized outsourced services.

Co-operations with other companies and sub-contractors managed through AKP (e.g. Data Management companies, Laboratories, etc.) allow us to broaden our service portfolio and to offer you even more customized solutions to your specific demand.

AKP's well known engaged services are based on reliable, high quality.

Our work is target-oriented, dedicated and cooperative, scientifically exact, and our flexibility guarantees you cost competitive solutions. AKP works diligently to insure compliance with timelines our clients set.

Management

Hilde Huber, Dipl.-Biologist, has been the CEO of AKP since 2011. Previously, Mrs. Huber has served as the Co-Chair CEO and Director Clinical Operations.
The former CEO, Priv.-Doz. Dr. med. K.-U. Seiler stepped down in 2011 and is now working as the Chief Medical Officer at AKP.

 

Hilde Huber, Dipl.-Biologist ( CEO )

Graduate degree in biology, ECPM diploma in Pharmaceutical Medicine. Extensive experience in clinical trial monitoring and project management for AKP, Parke-Davis and Gödecke.

She joined AKP in 1997, became Director of Clinical Operations in 2001, and was appointed Co-Chair CEO in 2007. As CEO since 2011, Mrs. Huber is in charge of the monitoring sector, project management, quality assurance and internal training.

Mrs. Huber supports the implementation of the client’s project in offering consultancy regarding study design, clinical development planning and submission requirements.

Priv.-Doz. Dr. med. habil. K.-U. Seiler ( CMO )

Recognized specialist in clinical pharmacology and internal medicine. Longstanding career at the university of Kiel, Germany. Pharmaceutical industry experience since 1985 as Head of Clinical Research for Janssen (Germany), and later Head of Cardiovascular Clinical Research for Parke-Davis.

Dr. med. K.-U. Seiler is responsible for the internal and external consultancy in medical issues, medical training of AKP staff and medical writing of study & submission documents.

His large network of contacts with medical specialists and hospitals predestines him to take over the feasibility assessments and recruitment of study sites. He can fall back on a data base of sites which have proven their compliance, efficiency and high quality.

 

Our Team

Our field force monitoring team consists of experienced and high-skilled professionals coming from diverse backgrounds, including Physicians, Biologists, Eco-Trophologists and Medical Documentation Specialists. They have experience in phases I - IV clinical trials, IITs, NIS and Medical Device studies for various therapeutic areas.

Our training programs as well as regular co-monitoring visits and the support of a senior staff member as a mentor ensure not only compliance with applicable local laws, regulations and guidelines, but also a study conduct and documentation quality on highest level.
.